A possible probiotic (S. salivarius K12) approach to improve oral and lung microbiotas and raise defenses against SAR S-CoV-2

Minerva Med. 2020 Jun;111(3):281-283. doi: 10.23736/S0026-4806.20.06570-2. Epub 2020 Apr 7.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19
  • Coronavirus Infections / prevention & control*
  • Humans
  • Lung / immunology
  • Lung / microbiology*
  • Microbiota* / immunology
  • Mouth / immunology
  • Mouth / microbiology*
  • Pandemics / prevention & control*
  • Pneumonia, Viral / prevention & control*
  • Probiotics / therapeutic use*
  • Streptococcus salivarius*